Interactions between THC and cannabidiol in mouse models of cannabinoid activity

Psychopharmacology

Volumn 186, Issue 2, 2006, Pages 226-234

  Varvel, S A ^a   Wiley, J L ^a   Yang, R ^a   Bridgen, D T ^a   Long, K ^a   Lichtman, A H ^a   Martin, B R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antinociception; Cannabidiol; Inhalation; Intravenous; Marijuana 9 THC; Tetrad

Indexed keywords

CANNABIDIOL; CANNABINOID; DRONABINOL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HYPOTHERMIA; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BODY TEMPERATURE REGULATION; BRAIN; CANNABIDIOL; CATALEPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INHALATION EXPOSURE; INJECTIONS, INTRAVENOUS; MALE; MARIJUANA SMOKING; MICE; MICE, INBRED ICR; MODELS, ANIMAL; MOTOR ACTIVITY; PAIN THRESHOLD; TETRAHYDROCANNABINOL;

EID: 33646558622     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0356-9     Document Type: Article

References (45)

1. 9-tetrahydrocannabinol and cannabidiol on intestinal motility in mice. J Pharm Pharmacol 26:136-137
2. Berman JS, Symonds C, Birch R (2004) Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 112:299-306
3. Bliss CI (1967) Statistics in biology; statistical methods for research in the natural sciences. McGraw-Hill
4. 9-tetrahydrocannabinol. Res Commun Chem Pathol Pharmacol 7:663-670
5. Bornheim LM, Everhart ET, Li J, Correia MA (1993) Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochem Pharmacol 45:1323-1331
6. Bornheim LM, Kim K, Beatrice J, Perotti Y, Benet L (1995) Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab Dispos 23: 825-831
7. Brady KT, Balster RL (1980) The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys. Psychopharmacology (Berl) 72:21-26
8. Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ (2004) An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 10:425-433
9. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:825-852
10. Colquhoun D (1971) Lectures on biostatistics: an introduction to statistics with applications in biology and medicine. Clarendon
11. Costa B, Giagnoni G, Franke C, Trovato AE, Colleoni M (2004) Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. Br J Pharmacol 143:247-250
12. D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharm Exp Ther 72:74-79
13. 9-tetrahydrocannabinol on operant behavior. Res Commun Chem Pathol Pharmacol 9:453-462
14. ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF 3rd (2000) Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997. J Forensic Sci 45:24-30
15. 9-THC actions by cannabinol and cannabidiol in the rat. Psychopharmacologia 38:329-338
16. Finn DP, Beckett SR, Roe CH, Madjd A, Fone KC, Kendall DA, Marsden CA, Chapman V (2004) Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci 19:678-686
17. 9-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice. Psychopharmacologia 41:169-174
18. Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J (2000) Neuroprotective antioxidants from marijuana. Ann N Y Acad Sci 899:274-282
19. Harvey DJ (1984) Chemistry, metabolism, and pharmacokinetics of the cannabinoids. In: Nahas GG (ed) Marijuana in science and medicine. Raven, New York, NY, pp 33-107
20. Jaeger W, Benet LZ, Bornheim LM (1996) Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes. Xenobiotica 26:275-284
21. Jones G, Pertwee RG (1972) A metabolic interaction in vivo between cannabidiol and 1-tetrahydrocannabinol. Br J Pharmacol 45:375-377
22. 9-tetrahydrocannabinol. Psychopharmacologia 33:53-70
23. 9-tetrahydrocannabinol in man. Eur J Pharmacol 28:172-177
24. Levy S, McCallum NK (1975) Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol. Experientia 31: 1268-1269
25. Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR (2001) The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug Alcohol Depend 63:107-116
26. Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80:448-456
27. Mechoulam R, Parker LA, Gallily R (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42:11S-19S
28. Nicholson AN, Turner C, Stone BM, Robson PJ (2004) Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24:305-313
29. Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE (1986) Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom 13:77-83
30. Pertwee R (2004) The pharmaology and therapeutic potential of cannabidiol. In: Di Marzo V (ed) Cannabinoids. Kluwer Academic, Dordrecht, Netherlands
31. Pertwee RG (1972) The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Br J Pharmacol 46:753-763
32. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180
33. Rakhshan F, Day TA, Blakely RD, Barker EL (2000) Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J Pharmacol Exp Ther 292:960-967
34. Rog DJ, Nurmikko TJ, Friede T, Young CA (2005) Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65:812-819
35. Russo E, Guy GW (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 66(2):234-246
36. Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30:1037-1043
37. Sanders J, Jackson DM, Starmer GA (1979) Interactions among the cannabinoids in the antagonism of abdominal constriction response in the mouse. Psychopharmacology (Berl) 61:281-285
38. Sofia RD, Vassar HB, Knobloch LC (1975) Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacologia 40:285-295
39. Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH (2005) Delta9-tetrahydrocannabinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J Pharmacol Exp Ther 314:329-337
40. Wade DT, Robson P, House H, Makela P, Aram J (2003) A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehab 17:21-29
41. Wade DT, Makela P, Robson P, House H, Bateman C (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 10:434-441
42. Watanabe K, Arai M, Narimatsu S, Yamamoto I, Yoshimura H (1987) Self-catalyzed inactivation of cytochrome P-450 during microsomal metabolism of cannabidiol. Biochem Pharmacol 36:3371-3377
43. Watanabe K, Kayano Y, Matsunaga T, Yamamoto I, Yoshimura H (1996) Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol Pharm Bull 19: 1109-1111
44. Welburn PJ, Starmer GA, Chesher GB, Jackson DM (1976) Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions. Psychopharmacologia 46:83-85
45. 9-THC in normal subjects. Psychopharmacology (Berl) 76: 245-250